Today is the expiration of September options and three of our positions will likely expire for full profits, and one will likely be a small loss or gain come Monday. Overall, it’s been another great month for us.
Read More
Today’s recommendation is a young, fast grower in a sector that has enormous growth potential.
Read More
Stock
Price Bought
Date Bought
Price 9/8/21
Profit
Rating
Altimeter Growth Corp. (AGC)
14
4/15/21
11
-21%
Buy a Half
ChargePoint Holdings (CHPT)
21
8/19/21
22
4%
Buy a Half
Cloudflare, Inc. (NET)
24
4/30/20
128
434%
Hold a Half
Fisker (FSR)
15
2/4/21
14
-7%
Buy a Half
International Business Machines (IBM)
130
1/7/21
139
7%
Buy a Half
Marvell Technology Group (MRVL)
50
4/1/21
60
21%
Buy a Half
Novonix (NVNXF)
2
8/6/21
4
79%
Buy a Half
Palantir Technologies (PLTR)
22
5/27/21
26
16%
Buy a Half
Pershing Holdings...
Read More
The market is strong, our portfolio is full, and the prospects for the months ahead look good. Thus I continue to recommend that you be heavily invested in stocks that help you meet your investing goals.
Read More
The market is strong, our portfolio is full, and the prospects for the months ahead look good. Thus I continue to recommend that you be heavily invested in stocks that help you meet your investing goals.
Read More
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Short-term, the market remains under pressure, buffeted by the selling of investors scared by the prospects of an extended tariff war, but long-term, the trend remains up, so we still see the current weakness as a normal correction.
Read More
A CORNUCOPIA OF TRADING & INVESTING IDEAS
Two stocks are leaving the Buy Low Opportunities Portfolio today as they near their price targets: Alaska Air Group (ALK) and Synchrony Financial (SYF). While researching stocks that might join our portfolios, I came across half a It...
Read More
Short-term, the market remains under pressure, buffeted by the selling of investors scared by the prospects of an extended tariff war, but long-term, the trend remains up, so we still see the current weakness as a normal correction.
Read More
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Short-term, the market remains under pressure, buffeted by the selling of investors scared by the prospects of an extended tariff war, but long-term, the trend remains up, so we still see the current weakness as a normal correction.
Read More
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Market Views
Quiet for Now
Stocks finished a relatively quiet session lower today, after trading on both sides of breakeven amid waning optimism over Friday's partial trade deal between Beijing and Washington. Reports emerged that China wishes to continue trade talks before finalizing the "phase deal,...
Read More
Short-term, the market remains under pressure, buffeted by the selling of investors scared by the prospects of an extended tariff war, but long-term, the trend remains up, so we still see the current weakness as a normal correction.
Read More
Patience Precedes Profits
We regularly write about practicing patience with your winning stocks, and that will always be a key factor in making big money—unless you’re a savant, you’ll find that many of your trades will offset over time (small losses, break-evens, small wins, with...
Read More
THE BIG IDEA
There are over 100 million people around the world suffering from obstructive sleep apnea (OSA), a condition in which a partially blocked airway prevents airflow to the lungs when a person is asleep. The typical length of a breathing pause is seconds...
Read More
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Short-term, the market remains under pressure, buffeted by the selling of investors scared by the prospects of an extended tariff war, but long-term, the trend remains up, so we still see the current weakness as a normal correction.
Read More
Aggravation-to-Profit Ratio: High
Everybody loves a persistent uptrend in growth stocks, especially us; we know how to find the winners and ride them for the majority of their advance. That’s where the real money is! And while we don’t ever root for a big we...
Read More
The Great Migration, or “Normal” Rotation?
In each of the last three years September has kicked off a wave of growth stock selling that rivals the magnificence of the Great Wildebeest migration across Northern Tanzania and Kenya.
It has been, at times, pure chaos. Investors seem...
Read More
